Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 3Gynecologic 2Genitourinary 2Gastrointestinal 2Thoracic 1Sarcoma 1Other solid neoplasm 1Head & Neck 1Dermatologic 1CNS 1Breast 1

Conditions

Breast Neoplasms 20Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Testicular Germ Cell Tumor 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Salivary Gland Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Myeloma 1Mesothelioma, Malignant 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1

Interventions

Cyclophosphamide 6Therapeutics 5Flow Cytometry 5Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Filgrastim 4Polymerase Chain Reaction 3Immunoenzyme Techniques 3sargramostim 2liposomal amphotericin B 2aldesleukin 2Stem Cell Factor 2Psychiatric Rehabilitation 2Ondansetron 2Mycophenolic Acid 2Methylprednisolone 2Melphalan 2Itraconazole 2Immunologic Techniques 2Etoposide 2Dexamethasone 2Caspofungin 2Calcium Dobesilate 2Aprepitant 2Antilymphocyte Serum 2Amplified Fragment Length Polymorphism Analysis 2Amifostine 2Alemtuzumab 2thymoglobulin 1temsirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × Microarray Analysis × Breast × Clear all
NCT00904514 2018-10-05

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

National Institutes of Health Clinical Center (CC)

Terminated
241 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmOther solid neoplasmThoracic

Congenital Abnormalities, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Brenner Tumor, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sezary Syndrome, Stomach Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡